A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2

After the pandemic of COVID-19, neutralizing antibodies (NAbs) against SARS-CoV-2 have been developed for the prophylactic and therapeutic purposes. However, few methodologies are described in detail on how to rapidly and efficiently generate effective NAbs to SARS-CoV-2. Here, we integrated and opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiaojian, Wang, Yingming, Li, Shenglong, Hu, Chao, Li, Tingting, Gu, Chenjian, Wang, Kai, Shen, Meiying, Wang, Jianwei, Hu, Jie, Wu, Ruixin, Mu, Song, Gong, Fang, Chen, Qian, Gao, Fengxia, Huang, Jingjing, Long, Yingyi, Luo, Feiyang, Song, Shuyi, Long, Shunhua, Hao, Yanan, Li, Luo, Wu, Yang, Xu, Wei, Cai, Xia, Gao, Qingzhu, Zhang, Guiji, He, Changlong, Deng, Kun, Du, Li, Nai, Yaru, Wang, Wang, Xie, Youhua, Qu, Di, Huang, Ailong, Tang, Ni, Jin, Aishun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019923/
https://www.ncbi.nlm.nih.gov/pubmed/33828563
http://dx.doi.org/10.3389/fimmu.2021.653189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019923/
https://www.ncbi.nlm.nih.gov/pubmed/33828563
http://dx.doi.org/10.3389/fimmu.2021.653189

Ejemplares similares